SOPHiA GENETICS’s $77 Million Series E Investment Round

SOPHiA GENETICS, a leading Swiss health tech company, closed a $77 million Series E investment round. The round was led by Generation Investment Management, a pioneer…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here